Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹33Cr
Food - Processing - Others
Rev Gr TTM
Revenue Growth TTM
-16.62%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TCMLMTD
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 261.0 | 1,075.8 | 394.1 | 1,330.4 | 75.0 | -27.6 | 36.9 | -45.3 | -10.9 | -39.2 | -14.2 | -7.9 |
| 6 | 8 | 7 | 11 | 9 | 6 | 7 | 7 | 8 | 5 | 7 | 6 |
Operating Profit Operating ProfitCr |
| -15.5 | -9.9 | -32.5 | 6.9 | -7.7 | -19.7 | -8.4 | -9.6 | 0.8 | -61.1 | -14.0 | -9.7 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 1 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | -1 | -2 | 1 | 0 | -1 | -1 | -1 | 4 | -2 | -1 | -1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 73.5 | 31.9 | -171.9 | 149.3 | 57.3 | -41.6 | 63.2 | -230.4 | 957.5 | -115.6 | -29.7 | -31.1 |
| -22.4 | -10.6 | -34.5 | 6.1 | -5.5 | -20.6 | -9.3 | -14.6 | 52.7 | -73.2 | -14.0 | -20.7 |
| -1.4 | -0.9 | -2.2 | 1.0 | -0.5 | -1.3 | -0.8 | -1.2 | 5.4 | -3.0 | -1.1 | -1.5 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 132.3 | 361.8 | -16.4 | 106.7 | 338.7 | -19.3 | -13.6 |
| 1 | 2 | 5 | 8 | 11 | 34 | 28 | 26 |
Operating Profit Operating ProfitCr |
| -248.9 | -91.1 | -21.1 | -112.8 | -50.0 | -7.0 | -8.3 | -14.6 |
Other Income Other IncomeCr | 0 | 1 | 1 | -2 | 0 | 0 | 4 | 5 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | 0 | 0 | -6 | -4 | -2 | 1 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | 132.1 | -61.1 | -5,065.5 | 27.3 | 46.4 | 161.1 | -123.6 |
| -239.3 | 33.1 | 2.8 | -165.4 | -58.1 | -7.1 | 5.4 | -1.5 |
| -1.7 | 0.9 | 0.2 | -9.4 | -6.0 | -2.6 | 2.2 | -0.2 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 3 | 3 | 3 | 7 | 7 | 7 | 7 |
| 29 | 29 | 29 | 22 | 23 | 21 | 23 | 20 |
Current Liabilities Current LiabilitiesCr | 17 | 13 | 15 | 17 | 19 | 36 | 47 | 49 |
Non Current Liabilities Non Current LiabilitiesCr | 20 | 20 | 20 | 20 | 20 | 20 | 0 | 8 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 9 | 5 | 6 | 5 | 9 | 45 | 42 | 64 |
Non Current Assets Non Current AssetsCr | 60 | 60 | 62 | 57 | 59 | 38 | 34 | 20 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -2 | -1 | 0 | -4 | -11 | 2 | -10 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | -1 | 4 | 6 | -1 | 0 |
Financing Cash Flow Financing Cash FlowCr | 5 | -3 | 0 | 0 | 5 | -1 | 10 |
|
Free Cash Flow Free Cash FlowCr | -2 | -1 | 0 | -1 | -13 | 1 | -11 |
| 172.2 | -187.6 | 327.1 | 71.6 | 254.4 | -85.1 | -720.2 |
CFO To EBITDA CFO To EBITDA% | 165.6 | 68.2 | -43.2 | 105.0 | 295.6 | -86.9 | 466.1 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 16 | 0 | 14 | 16 | 25 | 41 | 27 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 114.3 | 0.0 | 0.0 | 0.0 | 16.6 |
Price To Sales Price To Sales | 40.6 | 0.0 | 3.2 | 4.7 | 3.4 | 1.3 | 1.0 |
Price To Book Price To Book | 0.5 | 0.0 | 0.4 | 0.7 | 0.8 | 1.4 | 0.9 |
| -18.1 | -6.7 | -21.6 | -5.7 | -7.1 | -18.2 | -17.4 |
Profitability Ratios Profitability Ratios |
| -6.7 | 29.1 | 55.8 | 26.7 | 21.0 | 27.9 | 30.1 |
| -248.9 | -91.1 | -21.1 | -112.8 | -50.0 | -7.0 | -8.3 |
| -239.3 | 33.1 | 2.8 | -165.4 | -58.1 | -7.1 | 5.4 |
| -2.5 | 0.8 | 0.8 | -18.4 | -12.5 | -7.3 | 4.7 |
| -2.9 | 0.9 | 0.4 | -23.2 | -13.9 | -8.0 | 4.6 |
| -1.4 | 0.5 | 0.2 | -9.6 | -6.2 | -2.7 | 1.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
TCM Limited is an Indian multi-sector conglomerate currently undergoing a strategic transformation. Historically a chemical manufacturer, the company has successfully pivoted into a diversified holding structure with interests spanning **Real Estate Development**, **Agribusiness**, **Renewable Energy**, **Healthcare Diagnostics**, and **EdTech**. The company is focused on unlocking value from its legacy land bank to fuel expansion into high-growth, technology-driven sectors.
---
### **Strategic Pivot & Asset Monetization Framework**
TCM Limited is executing a structured transition from legacy manufacturing to a diversified operational model. The core of this strategy involves the monetization of non-productive assets to fund new ventures.
* **Kalamassery Land Development:** The company successfully resolved a long-standing liability with **Godrej Properties Limited** in March 2025, paying **₹15.01 Crore** to discharge a charge on its **11-acre** land bank. This has paved the way for a Joint Venture with **Asset Homes** to develop residential villas and flats.
* **Debt Resolution & Bridge Financing:** To facilitate clear titles for development, the company secured a **₹25 Crore** loan from **Asset Homes TCM Townships Pvt Ltd**.
* **Asset Divestments:** The company is aggressively offloading non-core holdings:
* Reclassified land in **Ulundurpet** and **Mettur** (carrying value **₹1,970.34 Lakhs**) as **Assets held-for-sale**.
* Sold a portion of the **Ulundurpet** land for **₹60 Lakhs** in early 2025.
* Authorized the sale of **7.064 acres** in **Tuticorin, Tamil Nadu**.
* **Recurring Income Generation:** In November 2024, the company reclassified **₹519.81 Lakhs** of inventory to **Investment Property**. This includes **11,382 Sq Ft** of commercial space at the **Hi-Lite building, Maradu**, leased to **Indus Towers Limited** for nearly **9 years**.
---
### **Segmented Business Operations**
The Group manages its operations through four distinct reportable segments, showing significant revenue volatility as it scales new verticals.
| Segment | FY 2024-25 (₹ Lakhs) | FY 2023-24 (₹ Lakhs) | FY 2022-23 (₹ Lakhs) |
| :--- | :---: | :---: | :---: |
| **Manufacturing** | **1,087.21** | **1,245.62** | **64.19** |
| **Real Estate** | **713.57** | **94.92** | **-** |
| **Trading** | **671.96** | **1,824.19** | **650.26** |
| **Educational** | **127.87** | **58.46** | **20.31** |
| **Total Revenue** | **2,600.61** | **3,223.19** | **734.76** |
#### **1. Agribusiness & Manufacturing**
This is currently the largest revenue contributor. The company produces **cattle and poultry feed**.
* **Expansion:** Leased a **10,760 Sq Ft** factory in Palakkad (September 2025).
* **Acquisition:** Signed a binding MoU to acquire **100%** of **Better Feeds Private Limited** for **₹7.65 Crore**.
* **Contract Manufacturing:** Entered an MoU with **Biogenix Inc Pvt Ltd** (May 2024) for diagnostic reagents.
#### **2. Healthcare Diagnostics (fluorecare Platform)**
Operated via **TCM Healthcare Private Limited**, the company provides a **Quantitative Point-of-Care Testing (POCT)** platform using **Immunofluorescence** technology.
* **Diagnostic Scope:** Covers Tumor Markers (CEA, PSA), Cardiac Markers (Troponin, D-dimer), Diabetes (HbA1c), and Thyroid profiles.
* **Hardware Ecosystem:** Includes the **T 25 Digital Dry Block Incubator**, **SMD-01 Vortex Mixer**, and **HM-01 Hematology Blood Mixer**.
* **Infrastructure:** Opened a new **1,621 Sq Ft** Healthcare Division office in Ernakulam in November 2025.
#### **3. Renewable Energy & Trading**
Through **TCM Solar Private Limited**, the company focuses on the installation and commissioning of **Solar Power Plants**. The trading arm also manages medical diagnostics, autocare, and audio products.
#### **4. EdTech & AI Learning**
Operated through **iSpark Learning Solutions (76.01% stake)**, this segment focuses on e-learning platforms integrated with **Artificial Intelligence**.
---
### **Financial Profile & Capital Structure**
TCM has stabilized its balance sheet through equity infusion and strategic reclassifications.
* **Equity Base:** Total equity stood at **₹3,784.23 Lakhs** as of March 2025. A prior **Rights Issue** raised **₹10.20 Crore** at **₹25 per share**, with promoters converting **₹5 Crore** of debt into equity.
* **Profitability:** Recorded a Net Profit After Tax of **₹3.26 Crore** on a turnover of **₹29.51 Crore** in FY25.
* **One-time Gains:** Recorded a **₹420.77 Lakhs** liability write-back in FY25 following the Kalamassery land settlement.
* **Borrowing Profile:**
* **Fixed Rate Exposure:** Increased to **₹1,109.15 Lakhs** (March 2025), primarily vehicle and equipment loans (**7.5% - 12.3% p.a.**).
* **Liquidity:** Utilizes interest-free, repayable-on-demand loans from directors and an overdraft facility (at **11.90%**) secured by land.
---
### **Risk Management & Governance**
The company operates under a Board-led risk framework to manage its multi-sector exposure.
* **Concentration Risk:** A single customer accounted for over **10%** of total revenue in FY25, indicating a need for client diversification.
* **Credit & Liquidity:** Uses **Ind AS 109 ECL models** to manage trade receivables (typically **30–180 days**). The company relies on holding company support for short-term liquidity.
* **Operational Risks:** Identified **Revenue Recognition (cut-off risk)** as a Key Audit Matter due to diverse regional delivery timelines.
* **Regulatory/Labor Risks:** Recently transitioned to formal actuarial valuations for gratuity. The company settled a long-standing dispute with Mettur division employees for **₹69.36 Lakhs** (including interest).
* **Market Risk:** While the company imports healthcare equipment, it currently reports **zero unhedged foreign currency exposure**. It uses **Level 1 derivatives** to manage gold and forex price fluctuations when necessary.
---
### **Subsidiary Ecosystem**
| Entity | Ownership | Focus Area |
| :--- | :---: | :--- |
| **TCM Healthcare Pvt Ltd** | **100%** | Diagnostic equipment and reagents |
| **TCM Solar Pvt Ltd** | **100%** | Renewable energy projects |
| **TCM Properties Pvt Ltd** | **100%** | Infrastructure and township development |
| **iSpark Learning Solutions** | **76.01%** | AI-based EdTech platforms |